NNZ-2566: Phase I data

In a dose-escalation, Australian Phase I trial in 28 healthy volunteers, NNZ-2566 was safe at the maximum tolerated dose of 20 mg/kg delivered via a 10 minute infusion. Early this year, NEU plans to b...